REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmaciya-Ekstempore OOO (Фармация-Экстемпоре ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Farmaciya-Ekstempore OOO Profile Updated: October 16, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Farmaciya-Ekstempore OOO (Фармация-Экстемпоре ООО) is a company in Russia, with a head office in Angarsk. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on November 10, 2004. There was a net sales revenue increase of 48.19% reported in Farmaciya-Ekstempore OOO (Фармация-Экстемпоре ООО)’s latest financial highlights for 2025. Over the same period, its total assets grew by 8.69%. The net profit margin of Farmaciya-Ekstempore OOO (Фармация-Экстемпоре ООО) increased by 32.07% in 2025.

Headquarters
8, 14
Angarsk; Irkutsk Oblast; Postal Code: 665831

Contact Details: Purchase the Farmaciya-Ekstempore OOO (Фармация-Экстемпоре ООО) report to view the information.

Basic Information
Registered Capital:
Purchase the Farmaciya-Ekstempore OOO (Фармация-Экстемпоре ООО) report to view the information.
Financial Auditors:
Purchase the Farmaciya-Ekstempore OOO (Фармация-Экстемпоре ООО) report to view the information.
Incorporation Date:
November 10, 2004
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Farmaciya-Ekstempore OOO (Фармация-Экстемпоре ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
48.19%▲
Total Operating Revenue
48.19%▲
Operating Profit
414.25%▲
Net Profit/Loss for the Period
1445.93%▲
Total Assets
8.69%▲
Total Equity
124.62%▲
Operating Profit Margin
28.03%▲
Net Profit Margin
32.07%▲
Return on Equity (ROE)
69.36%▲
Debt / Equity
-52.87%▼
Quick Ratio
0.52%▲
Cash Ratio
0.1%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?